728 related articles for article (PubMed ID: 33743479)
1. Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic.
Matsuo K; Shimada M; Matsuzaki S; Enomoto T; Mikami M
Eur J Cancer; 2021 May; 148():117-120. PubMed ID: 33743479
[No Abstract] [Full Text] [Related]
2. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
3. Influence of lymph vascular space invasion on prognosis of patients with early-stage cervical squamous cell carcinoma.
Yan M; Zhang YN; He JH; Sun JR; Sun XM
Chin J Cancer; 2010 Apr; 29(4):425-30. PubMed ID: 20346220
[TBL] [Abstract][Full Text] [Related]
4. Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.
Chai Y; Wang T; Wang J; Yang Y; Gao Y; Gao J; Gao S; Wang Y; Zhou X; Liu Z
BMC Cancer; 2014 Feb; 14():63. PubMed ID: 24495453
[TBL] [Abstract][Full Text] [Related]
5. Wait-time for hysterectomy and survival of women with early-stage cervical cancer: A clinical implication during the coronavirus pandemic.
Matsuo K; Novatt H; Matsuzaki S; Hom MS; Castaneda AV; Licon E; Nusbaum DJ; Roman LD
Gynecol Oncol; 2020 Jul; 158(1):37-43. PubMed ID: 32425268
[TBL] [Abstract][Full Text] [Related]
6. Effect of delay in surgical therapy for early-stage cervical cancer: An implication in the coronavirus pandemic.
Matsuo K; Huang Y; Matsuzaki S; Klar M; Wright JD
Eur J Cancer; 2020 Nov; 139():173-176. PubMed ID: 32992156
[No Abstract] [Full Text] [Related]
7. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone.
Matsuo K; Nusbaum DJ; Machida H; Huang Y; Khetan V; Matsuzaki S; Klar M; Grubbs BH; Roman LD; Wright JD
Am J Obstet Gynecol; 2020 May; 222(5):484.e1-484.e15. PubMed ID: 31678092
[TBL] [Abstract][Full Text] [Related]
8. Early stage cervical cancer with negative pelvic lymph nodes: pattern of failure and complication following radical hysterectomy and adjuvant radiotherapy.
Chen SW; Liang JA; Yang SN; Lin FJ
Eur J Gynaecol Oncol; 2004; 25(1):81-6. PubMed ID: 15053068
[TBL] [Abstract][Full Text] [Related]
9. Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer.
Hanprasertpong J; Jiamset I; Geater A; Leetanaporn K; Peerawong T
J Gynecol Oncol; 2017 Jul; 28(4):e42. PubMed ID: 28541633
[TBL] [Abstract][Full Text] [Related]
10. Management of early-stage cervical carcinoma by modified (Type II) radical hysterectomy.
Michalas S; Rodolakis A; Voulgaris Z; Vlachos G; Giannakoulis N; Diakomanolis E
Gynecol Oncol; 2002 Jun; 85(3):415-22. PubMed ID: 12051867
[TBL] [Abstract][Full Text] [Related]
11. Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic.
Matsuo K; Huang Y; Matsuzaki S; Ragab OM; Roman LD; Wright JD
Gynecol Oncol; 2021 May; 161(2):414-421. PubMed ID: 33771396
[TBL] [Abstract][Full Text] [Related]
12. The outcomes and quality of life of young patients undergoing adjuvant radiotherapy versus non-radiotherapy following surgery treating early FIGO stage cervical squamous cell cancer in southwestern China.
Yang L; Yuan J; Zeng X; Xi M; Wang H
Sci Rep; 2020 Jun; 10(1):9583. PubMed ID: 32533117
[TBL] [Abstract][Full Text] [Related]
13. Surgical pathologic factors in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection: association with administration of adjuvant radiotherapy and effect on survival.
Piura B; Rabinovich A; Friger M
Eur J Gynaecol Oncol; 2006; 27(6):573-8. PubMed ID: 17290585
[TBL] [Abstract][Full Text] [Related]
14. Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications.
Sandadi S; Tanner EJ; Khoury-Collado F; Kostolias A; Makker V; Chi DS; Sonoda Y; Alektiar KM; Barakat RR; Abu-Rustum NR
Int J Gynecol Cancer; 2013 Mar; 23(3):553-8. PubMed ID: 23392402
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984-1996).
Snijders-Keilholz A; Hellebrekers BW; Zwinderman AH; van de Vijver MJ; Trimbos JB
Radiother Oncol; 1999 May; 51(2):161-7. PubMed ID: 10435808
[TBL] [Abstract][Full Text] [Related]
16. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
[TBL] [Abstract][Full Text] [Related]
17. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
[TBL] [Abstract][Full Text] [Related]
18. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer.
Cusimano MC; Baxter NN; Gien LT; Moineddin R; Liu N; Dossa F; Willows K; Ferguson SE
Am J Obstet Gynecol; 2019 Dec; 221(6):619.e1-619.e24. PubMed ID: 31288006
[TBL] [Abstract][Full Text] [Related]
19. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
[TBL] [Abstract][Full Text] [Related]
20. Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation.
Matsuo K; Shimada M; Aoki Y; Sakamoto M; Takeshima N; Fujiwara H; Matsumoto T; Mikami M; Sugiyama T
Int J Cancer; 2017 Sep; 141(5):1042-1051. PubMed ID: 28524247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
